We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

STANDARD DIAGNOSTICS INC.

Standard Diagnostics develops rapid diagnostic tests that make it possible to diagnose various diseases at an earlier... read more Featured Products: More products

Download Mobile App




Malaria Parasite Evades Rapid Test Detection in Children

By LabMedica International staff writers
Posted on 30 Nov 2016
Print article
Image: The SD BIOLINE Malaria Ag P.f., rapid diagnostic test for Plasmodium falciparum (Photo courtesy of Standard Diagnostics).
Image: The SD BIOLINE Malaria Ag P.f., rapid diagnostic test for Plasmodium falciparum (Photo courtesy of Standard Diagnostics).
Rapid diagnostic tests account for more than 70% of diagnostic testing for malaria in Africa and most rapid test diagnostics rely on the detection an antigen specific to Plasmodium falciparum malaria.

The Democratic Republic of the Congo (DRC) has one of the highest rates of people living with malaria. Most rapid test diagnostics (RDT) rely on the detection of histidine-rich protein 2 (HRP2), an antigen specific to P. falciparum malaria. However, one of every 15 children infected with P. falciparum malaria parasites in the DRC is infected by a pfhrp2-deleted mutant, producing a false-negative result when an RDT is used.

An international team of scientists led by those at University of North Carolina Health Care System (Chapel Hill, NC, USA) collected samples from children under five years of age as part of the 2013- 2014 DRC Demographic and Health Survey. The majority of children were asymptomatic at the time of sample collection. Heel- or finger-prick blood from each participant was analyzed by light microscopy for parasites, applied to an RDT targeting the P. falciparum HRP2 antigen.

The samples were applied to an RDT targeting the P. falciparum HRP2 antigen (SD BIOLINE Malaria Ag P.f., Standard Diagnostics, Gyeonggi-do, Republic of Korea), and used to prepare dried blood spots (DBS). Three diagnostic methods were performed for each child: RDT, microscopy, and polymerase chain reaction (PCR). The real-time PCR assay with a limit of detection of 100 parasites/μL was employed to identify P. falciparum infection by amplifying a region of the single-copy pfldh gene.

The team focused on 783 samples with opposing rapid test diagnostic test and polymerase chain reaction (PCR) results. PCR testing showed positive results for malaria where rapid diagnostic testing did not. They identified 149 pfhrp2-deleted parasites, representing 6.4% of all P. falciparum infections country-wide among the 2,752 children diagnosed with P. falciparum infection by real-time PCR and 19.0 % of the 783 RDT-/PCR+ parasites tested.

Jonathan Parr, MD. MPH. the study's lead author, said, “This is the first nationwide study to demonstrate the presence and estimate the prevalence of malaria caused by pfhrp2-deleted P. falciparum in asymptomatic children. Because most rapid diagnostic tests in the DRC are HRP2-based, they will fail to detect these parasites. Their spread would represent a serious threat to malaria elimination efforts.” The study was published on November 14, 2016, in the Journal of Infectious Diseases.

Related Links:
University of North Carolina Health Care System
Standard Diagnostics
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.